Welcome to Nutraceuticals World   
October 2014 Issue
Last Updated Friday, October 24 2014
Print

Industry News

Related Searches:
November 1, 2008
Glucosamine and chondroitin sulfate, together or alone, do not effectively slow cartilage loss in the knees of osteoarthritis patients compared to placebo, according to a National Institutes of Health (NIH)-supported study. Researchers from the Gl…  Read More »
November 1, 2008
FDA estimates it will receive 856 adverse events reports (AERs) for dietary supplements during the first year of required reporting—about 100 fewer than it first estimated—based on the 214 mandatory accounts it received during the first q…  Read More »
October 1, 2008
More than 1000 prisoners in three U.K. penitentiaries will be subjects in a new study investigating the link between nutrition and behavior. Wellcome Trust, a U.K. charity that funds innovative biomedical research, has offered $2.6 million for the Ox…  Read More »
October 1, 2008
Despite considerable progress in re­search to understand the health effects of vitamin D, experts recently convened by the National Institutes of Health (NIH) to review the available data found major gaps in the evidence. The data are strongest i…  Read More »
October 1, 2008
Netherlands-based DSM Venturing, the corporate venturing unit of Royal DSM N.V., has acquired an equity stake of 29.3% in Provexis plc, becoming the company’s largest shareholder. Provexis develops and licenses ingredients for the functional…  Read More »
October 1, 2008
FDA has affirmed that barley betafiber can be included as a soluble fiber source, carrying the authorized health claim on the relationship between “soluble fiber from certain foods and coronary heart disease” (CHD). The final rule determi…  Read More »
October 1, 2008
Labeling on nutrition bars has become more accurate, according to a new report by ConsumerLab.com, White Plains, NY, which compared 20 protein, fiber, energy and whole food bars. Unlike tests in 2001 that found many undeclared carbohydrates along wit…  Read More »
October 1, 2008
Tokyo, Japan-based Kikkoman will construct a new research and development laboratory at University Research Park, a partner of University of Wisconsin-Madison. The lab, which joins two others in Singapore and the Netherlands, is the company’s f…  Read More »
October 1, 2008
With a first product launch scheduled for 2009, Nestlé Nutrition, Glendale, CA, has entered an agreement with BioGaia, Stockholm, Sweden, to in­clude the company’s patented probiotic Lactobacillus reuteri in child formula products fo…  Read More »
October 1, 2008
Pharmaceutical firm Sanofi-Aventis, Bridgewater, NJ, has announced that Chris Viehbacher, a former GlaxoSmithKline executive, will succeed Gerard Le Fur as CEO on Dec. 1st. Un­der Mr. Viehbacher, Sanofi-Aventis will attempt to diversify its activ…  Read More »
October 1, 2008
In a $315 million deal announced at the end of August, Glanbia plc, Kilkenny, Ireland, acquired Aurora, IL-based Optimum Nutrition, Inc. The business is being acquired on a debt-free basis and will be funded through Glanbia’s existing resources…  Read More »
October 1, 2008
Dortmund, Germany-based InterMed Discovery (IMD) and Biotropics Malaysia Berhad, Kuala Lumpur, have entered a long-term strategic agreement to investigate and commercialize products derived from Malaysia’s biodiversity and multicultural traditi…  Read More »
October 1, 2008
Focusing on popular consumer segments that are strong delivery vehicles for functional ingredients, FutureCeuticals, Inc., Momence, IL, and Comax Flavors, Melville, NY, have entered a strategic collaboration to combine flavor and nutritional ingredie…  Read More »
October 1, 2008
Knoxville, TN-based Nutraceutical Discoveries Inc. (NDI) has partnered with brand development company Attitude Drinks Incorporated, Palm Beach Gardens, FL, to create a functional dairy beverage containing Innutria, NDI’s blend of naturally occu…  Read More »
October 1, 2008
Neptune Technologies Bioressources, Laval, Quebec, Canada, has formed an operating pharmaceutical subsidiary named Acasti Pharma Inc., which will carry out the research, development and commercialization of active pharmaceutical ingredients for cardi…  Read More »

Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On